Published in J Med Life on January 01, 2015
Natural history of chronic hepatitis C. Hepatology (2002) 7.70
Treatment of hepatitis C: a systematic review. JAMA (2014) 4.99
Hepatitis C: the clinical spectrum of disease. Hepatology (1997) 3.94
Structure of the hepatitis C virus RNA helicase domain. Nat Struct Biol (1997) 3.80
The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients. Hepatology (2006) 2.35
Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis (2010) 2.32
Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol (2002) 2.21
Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol Infect (2013) 2.09
Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Collaboration of Australian NSPs. Med J Aust (2000) 1.92
Which patients with hepatitis C develop liver complications? Hepatology (2000) 1.73
Hepatitis C: a review for primary care physicians. CMAJ (2006) 1.60
Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology (2004) 1.48
The prevalence of hepatitis C virus in mashhad, iran: a population-based study. Hepat Mon (2013) 1.38
Hepatitis C genotypes: current trends and future implications. Mayo Clin Proc (1996) 1.38
Concern Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey. BMC Infect Dis (2014) 1.37
Hepatitis C and hepatitis B virus infection: epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran. Hepat Mon (2011) 1.09
Prevalence of hepatitis C virus infection in US Hispanic/Latino adults: results from the NHANES 2007-2010 and HCHS/SOL studies. J Infect Dis (2014) 1.07
Prevalence and risk factors of hepatitis C virus infection in amol city, north of iran: a population-based study (2008-2011). Hepat Mon (2013) 1.07
Estimating the prevalence of hepatitis C infection in New York City using surveillance data. Epidemiol Infect (2013) 0.93
High prevalence of anti-HCV antibodies in two metropolitan emergency departments in Germany: a prospective screening analysis of 28,809 patients. PLoS One (2012) 0.91
Neurologic complications of hepatitis C. Neurologist (2008) 0.87
Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease. World J Hepatol (2015) 0.86
Detection of hepatitis E virus in pork liver sausages. Int J Food Microbiol (2014) 0.83
Seroprevalence and predictors of hepatitis A infection in Nigerian children. Pan Afr Med J (2015) 0.82
The prevalence of hepatitis C virus infection and its related risk factors among the rural population of fars province, southern iran. Hepat Mon (2015) 0.81
Viruses, definitions and reality. Rev Biol Trop (2011) 0.79
Hepatitis B prevalence and incidence in Greenland: a population-based cohort study. Am J Epidemiol (2015) 0.79
Rescuing compound bioactivity in a secondary cell-based screening by using γ-cyclodextrin as a molecular carrier. Int J Nanomedicine (2015) 0.78
Hepatitis C virus antibody prevalence, demographics and associated factors among persons screened at Hawai'i community-based health settings, 2010-2013. Hawaii J Med Public Health (2015) 0.77
Estimating the true prevalence of hepatitis C in rhode island. R I Med J (2013) (2014) 0.77
Prevalence of Hepatitis B virus between Qeshm Island people in 2013-2014, Iran. J Med Life (2015) 0.75
Prevalence of HIV disease between Qeshm Island people during 2013-2014, Iran. J Med Life (2015) 0.75